2304372-79-8
Chemical Structure
Pocenbrodib
- CAS No.: 2304372-79-8
- Formula:C28H32FN3O6
- Molecular Weight:525.57
IUPAC Name: (1R,3R)-3-((S)-2-((R)-(5-fluoro-2-methoxyphenyl)(hydroxy)methyl)-6-(methoxycarbonyl)-7-methyl-6,7,8,9-tetrahydro-3H-imidazo[4,5-f]quinolin-3-yl)cyclohexane-1-carboxylic acid
InChIKey: NOUKMOKAEKAWKS-FSEQIFNCSA-N
SMILES: O[C@H](C1=C(C=CC(F)=C1)OC)C2=NC3=C(C=CC4=C3CC[C@@H](N4C(OC)=O)C)N2[C@@]5([H])C[C@@H](CCC5)C(O)=O
Biological Activity: Pocenbrodib is a P300/CBP inhibitor. Pocenbrodib blocks the function of P300/CBP and inhibits the acetylation of histones and non-histone proteins. Pocenbrodib may be used in research related to castration-resistant prostate cancer and other cancers[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Pocenbrodib | 98.48% | Pocenbrodib is a P300/CBP inhibitor. Pocenbrodib blocks the function of P300/CBP and inhibits the acetylation of histones and non-histone proteins. Pocenbrodib may be used in research related to castration-resistant prostate cancer and other cancers. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
- [1]. Purohit TA, et al. Histone-modifying enzymes as drivers and therapeutic targets in androgen-resistant prostate cancer. Front Endocrinol (Lausanne). 2026;16:1730397. Published 2026 Jan 12. [Content Brief]
- [2]. George Luke, et al. Inhibiting cyclic amp-responsive element-binding protein (creb). WO2020190780A1. 2021-09-15.
Keywords
